Circio logoCircio logo

  • About
      • About Circio
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
  • circRNA
      • Circio AB
      • circVec platform
  • Clinical programs
      • ONCOS-102
      • KRAS program
      • Publications
  • Partnering
  • Investors
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
      • Contact
  • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    • About
      • About Circio
      • Our pipeline
      • Management Team
      • Board of Directors
      • Collaborations
      • Careers
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • ONCOS-102
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Articles of Association
      • Contact
      • Subscribe
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media
    All press releases
    • Press releases - Regulatory
    • Press releases - Non-regulatory
    2015
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2014
    • 2013
    • 2012
    • 2011
    • All years
    All subjects
    • Corporate news
    • Other
    December 14, 2015
    Press release - Non-regulatory

    DNB’s 6th Annual Health Care Conference, Oslo, 15 December 2015

    December 9, 2015
    Press release - Non-regulatory

    Exercise of employee share options

    November 26, 2015
    Press release - Regulatory

    Targovax ASA: Interim report third quarter 2015

    November 19, 2015
    Press release - Regulatory

    Targovax ASA: Invitation to presentation of Targovax’ third quarter 2015 results

    November 18, 2015
    Press release - Regulatory

    Targovax ASA: LUDWIG CANCER RESEARCH AND CANCER RESEARCH INSTITUTE PARTNER WITH TARGOVAX TO TEST CANDIDATE VIROTHERAPY IN EARLY-PHASE CLINICAL TRIALS

    November 6, 2015
    Press release - Regulatory

    Targovax to present at upcoming investor Conferences

    November 5, 2015
    Press release - Regulatory

    Targovax ASA: Immunotherapy with ONCOS-102 show potential to activate immunologically silent tumors and reduce local immune suppression in advanced tumors

    September 14, 2015
    Press release - Non-regulatory

    Protocol from Extraordinary General Meeting

    September 14, 2015
    Press release - Non-regulatory

    Targovax appoints two new directors to its board

    August 28, 2015
    Press release - Non-regulatory

    Targovax AS: Interim Report Q2 and 1H 2015

    August 27, 2015
    Press release - Non-regulatory

    Notice of Extraordinary General Meeting

    July 9, 2015
    Press release - Non-regulatory

    Completion of NOK 200 million private placement

    July 2, 2015
    Press release - Non-regulatory

    Targovax AS: Closing of the acquisition of Oncos Therapeutics Oy

    June 22, 2015
    Press release - Non-regulatory

    Protocol from general Meeting

    June 18, 2015
    Press release - Non-regulatory

    Targovax announces successful NOK 200 million private placement

    June 15, 2015
    Press release - Non-regulatory

    Targovax increases size of private placement to NOK 200 million after strong investor demand

    June 11, 2015
    Press release - Non-regulatory

    Notice of Extraordinary General Meeting

    June 11, 2015
    Press release - Non-regulatory

    Targovax and Oncos Therapeutics join forces to create a Nordic leader within immuno-oncology

    June 2, 2015
    Press release - Non-regulatory

    ASCO poster 2015

    June 1, 2015
    Press release - Non-regulatory

    Targovax presented safety data and immunological results at the 2015 ASCO Annual Meeting

    May 18, 2015
    Press release - Non-regulatory

    Targovax presents data at ASCO 2015 in Chicago

    May 12, 2015
    Press release - Non-regulatory

    Targovax AS: Interim Report Q1 2015

    May 7, 2015
    Press release - Non-regulatory

    MEET US: Bio-International, Philadephia, June 14-18 2015

    May 7, 2015
    Press release - Non-regulatory

    MEET US: ASCO, Chicago, June 1-3 2015

    April 28, 2015
    Press release - Non-regulatory

    Protocol from general Meeting

    April 20, 2015
    Press release - Non-regulatory

    Notice of general assembly

    April 20, 2015
    Press release - Non-regulatory

    Targovax ASA: Oncos Therapeutics presenting at the Anglonordic Life Science Conference on April 23rd in London, UK.

    April 17, 2015
    Press release - Regulatory

    Annual report 2014 – IFRS

    April 16, 2015
    Press release - Regulatory

    Annual report 2014 – NGAAP

    April 13, 2015
    Press release - Non-regulatory

    Targovax has appointed Peter Skorpil as Head of Business Development, effective from April 8th, 2015.

    April 1, 2015
    Press release - Non-regulatory

    Targovax Presentation Arctic Biotech Seminar March 2015

    March 9, 2015
    Press release - Non-regulatory

    Targovax has decided to expand the on-going phase I/II clinical study CT-TG01-01 with a new group of up to 13 patients.

    February 26, 2015
    Press release - Non-regulatory

    Targovax ASA: Oncos represented at the 8th Annual Life Science CEO Forum & Exhibition March 3rd, 2015 in Zurich, Switzerland

    February 26, 2015
    Press release - Non-regulatory

    Targovax is pleased to announce Mr. Øystein Soug as the new CFO of the Company from June 1, 2015

    February 16, 2015
    Press release - Non-regulatory

    Interim Report Q4 and YTD 2014

    February 11, 2015
    Press release - Non-regulatory

    Protocol from general Meeting

    February 3, 2015
    Press release - Non-regulatory

    Notice of Extraordinary General Meeting

    January 26, 2015
    Press release - Non-regulatory

    Targovax ASA: ONCOS-102 Mechanism of Action -video released on the website

    January 22, 2015
    Press release - Non-regulatory

    Targovax strengthens management team

    January 12, 2015
    Press release - Non-regulatory

    Targovax ASA: ONCOS-102 granted US lung cancer orphan drug designation

    January 8, 2015
    Press release - Non-regulatory

    Targovax reports completion of recruitment of patients in the phase I/II clinical trial CT TG01-01

    IR contact
    Dr Lubor Gaal
    Dr Lubor Gaal
    Chief Financial Officer
    lubor.gaal@circio.com
    (+34) 683 343 811
    Renate Birkeli
    Renate Birkeli
    Investor Relations
    renate.birkeli@circio.com
    (+47) 922 61 624
    Circio logo

    Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines.

    • About
    • circRNA
    • Clinical programs
    • Partnering
    • Investors
    • Media
    • Contacts

    CONTACT

    Circio Holding ASA
    Email: contact@circio.com

    • Cookies
    • Privacy policy
    • STAY CONNECTED